Enzyme-blocker promises to reduce cardiovascular disease

Scientists have identified an enzyme that promotes heart disease–and found a molecule that blocks the effects of [the enzyme] ACAT2 (so far, it works in mice). “In studies of genetically altered mice that do not produce ACAT2, levels of atherosclerosis are 85 percent lower than animals producing ACAT2.”

Talk about discovering an exciting piece of the heart disease puzzle. These new results, presented today at the American Heart Association’s Sixth Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology, seem to hold the promise of conquering the genetic programming that sets people up for heart disease.

Amen, and where to next?